These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15902793)

  • 21. The synthesis, in vitro reactivity, and evidence for formation in humans of 5-phenyl-1,3-oxazinane-2,4-dione, a metabolite of felbamate.
    Thompson CD; Miller TA; Barthen MT; Dieckhaus CM; Sofia RD; Macdonald TL
    Drug Metab Dispos; 2000 Apr; 28(4):434-9. PubMed ID: 10725312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromatographic procedures for the determination of felbamate in serum.
    Gur P; Poklis A; Saady J; Costantino A
    J Anal Toxicol; 1995 Oct; 19(6):499-503. PubMed ID: 8926745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid and simple high-performance liquid chromatographic determination of felbamate in serum.
    Paw B; Misztal G; Skibiński R
    Acta Pol Pharm; 2003; 60(5):339-42. PubMed ID: 15005415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metabolite.
    Dieckhaus CM; Roller SG; Santos WL; Sofia RD; Macdonald TL
    Chem Res Toxicol; 2001 May; 14(5):511-6. PubMed ID: 11368548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic interaction studies between felbamate and vigabatrin.
    Reidenberg P; Glue P; Banfield C; Colucci R; Meehan J; Rey E; Radwanski E; Nomeir A; Lim J; Lin C
    Br J Clin Pharmacol; 1995 Aug; 40(2):157-60. PubMed ID: 8562299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigating the role of 2-phenylpropenal in felbamate-induced idiosyncratic drug reactions.
    Popović M; Nierkens S; Pieters R; Uetrecht J
    Chem Res Toxicol; 2004 Dec; 17(12):1568-76. PubMed ID: 15606131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of felbamate concentration in pediatric samples by high-performance liquid chromatography.
    Behnke CE; Reddy MN
    Ther Drug Monit; 1997 Jun; 19(3):301-6. PubMed ID: 9200771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Felbamate metabolism in the rat, rabbit, and dog.
    Yang JT; Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1126-34. PubMed ID: 1687020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystalluria: a neglected aspect of urinary sediment analysis.
    Fogazzi GB
    Nephrol Dial Transplant; 1996 Feb; 11(2):379-87. PubMed ID: 8671802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Felbamate in vitro metabolism by rat liver microsomes.
    Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1135-8. PubMed ID: 1687021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between human serum albumin and the felbamate metabolites 4-Hydroxy-5-phenyl-[1,3]oxazinan-2-one and 2-phenylpropenal.
    Roller SG; Dieckhaus CM; Santos WL; Sofia RD; Macdonald TL
    Chem Res Toxicol; 2002 Jun; 15(6):815-24. PubMed ID: 12067249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mechanistic approach to understanding species differences in felbamate bioactivation: relevance to drug-induced idiosyncratic reactions.
    Dieckhaus CM; Miller TA; Sofia RD; Macdonald TL
    Drug Metab Dispos; 2000 Jul; 28(7):814-22. PubMed ID: 10859156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low propensity of conventional antiepileptic drugs for interaction with felbamate against maximal electroshock-induced seizures in mice.
    Borowicz KK; Stasiuk G; Teter J; Kleinrok Z; Gasior M; Czuczwar SJ
    J Neural Transm (Vienna); 2000; 107(7):733-43. PubMed ID: 11005540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute, subchronic, and chronic toxicity studies with felbamate, 2-phenyl-1,3-propanediol dicarbamate.
    McGee JH; Erikson DJ; Galbreath C; Willigan DA; Sofia RD
    Toxicol Sci; 1998 Oct; 45(2):225-32. PubMed ID: 9848129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urolithiasis in patients on high dose felbamate.
    Ghousheh AI; Groth TW; Fryjoff KM; Wille DF; Mandel NS; Roddy JT; Durkee CT
    J Urol; 2013 May; 189(5):1865-9. PubMed ID: 23262038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of spontaneous crystalluria in patients with calcium oxalate calculi].
    Nguyen HV; Daudon M; Réveillaud RJ; Jungers P
    Nephrologie; 1987; 8(2):65-9. PubMed ID: 3614507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Totally automated analysis by robotized PrepStation and liquid chromatography: direct-sample analysis of felbamate.
    Wong SH; Sasse EA; Schroeder JM; Rodgers JK; Pearson ML; Neicheril JC; Radewahn KL; Morris GL
    Ther Drug Monit; 1996 Oct; 18(5):573-80. PubMed ID: 8885122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].
    Steinhoff BJ
    Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
    Adusumalli VE; Choi YM; Romanyshyn LA; Sparadoski RE; Wichmann JK; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1993; 21(4):710-6. PubMed ID: 8104132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic studies with felbamate (2-phenyl-1,3-propanediol dicarbamate).
    McGee JH; Butler WH; Erikson DJ; Sofia RD
    Toxicol Sci; 1998 Oct; 45(2):146-51. PubMed ID: 9848121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.